A hypothetical signaling loop with tumor progression triggered by heparanase overexpression and growth factors

Bioscience Hypotheses

Volumn 1, Issue 2, 2008, Pages 118-120

  Luan, Qi ^a   Sun, Jing ^a   Li, Chun Ying ^a   Li, Jie ^b   Lv, Ya Jie ^a   Li, Cheng Xin ^a   Wang, Gang ^a   Gao, Tian Wen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HEPARANASE;

ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 48349142634     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.03.001     Document Type: Article

References (5)

1. Edovitsky E., Elkin M., Zcharia E., Peretz T., and Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 96 16 (2004) 1219-1230
2. Zetser A., Bashenko Y., Edovitsky E., Levy-Adam F., Vlodavsky I., and Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66 3 (2006) 1455-1463
3. Vreys V., and David G. Mammalian heparanase: what is the message?. J Cell Mol Med 11 3 (2007) 427-452
4. Beeram M., Patnaik A., and Rowinsky E.K. Raf: a strategic target for therapeutic development against cancer. J Clin Oncol 23 27 (2005) 6771-6790
5. Scaltriti M., and Baselga J. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12 18 (2006) 5268-5272